Related Experiment Video
Updated: May 26, 2026

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
Published on: July 11, 2025
Trends in pathology malpractice claims
1The Doctors Company, Napa, CA, USA. dtroxel@thedoctors.com
Abstract:
Previously reported analyses of pathology malpractice claims reported to The Doctors Company from 1995 through 2003 uncovered repetitive patterns of specimen type and diagnostic category that contributed to claims. To determine whether these patterns had changed, 276 pathology malpractice claims from 2004 through 2010 were reviewed and are the subject of this report. Claims involving melanoma, breast (specimens and fine needle aspiration), system error, gynecologic cytology, and fine needle aspiration (excluding breast) accounted for 49% of the total claims. There has been a significant decline in the number of claims involving melanoma, breast, and gynecologic cytology, and the factors contributing to this decline are discussed.
Insights
Pathology malpractice claims analysis reveals shifts in claim patterns. While melanoma, breast, and gynecologic cytology claims declined, other areas remain significant contributors to litigation.
Area of Science:
- Medical Malpractice
- Pathology
- Legal Medicine
Background:
- Previous analysis (1995-2003) identified recurring patterns in pathology malpractice claims.
- These patterns involved specific specimen types and diagnostic categories contributing to litigation.
- The need to assess changes in these patterns over time was identified.
Purpose of the Study:
- To determine if patterns contributing to pathology malpractice claims have changed since previous analyses.
- To review pathology malpractice claims data from 2004 through 2010.
- To identify current trends and factors in pathology-related litigation.
Main Methods:
- Review of 276 pathology malpractice claims from 2004 to 2010.
- Analysis of claim data focusing on specimen type and diagnostic category.
- Comparison of current claim patterns with historical data from 1995-2003.
Main Results:
- Claims involving melanoma, breast (specimens and fine needle aspiration), system error, gynecologic cytology, and fine needle aspiration (excluding breast) constituted 49% of total claims.
- A significant decline was observed in claims related to melanoma, breast, and gynecologic cytology.
- Specific factors contributing to these observed declines are discussed in the report.
Conclusions:
- Pathology malpractice claim patterns have evolved since the early 2000s.
- Declines in claims for certain areas like melanoma and breast pathology suggest potential improvements or changes in practice.
- Continued monitoring of malpractice claims is essential for identifying emerging risks and informing patient safety initiatives.
Related Concept Videos
Torts I
Intentional...
Torts III
Quasi-intentional torts in healthcare involve acts where intent is not directed to harm an individual but results in harm due to careless or reckless speech.
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Torts II
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...